🏥 Health
7h ago
FDA Plans Ultra-Fast Review of Three Psychedelics for Depression, PTSD
Source ↗
👁 0
💬 0
(MedPage Today) -- The FDA said Friday it will offer ultra-fast review to three psychedelic drugs being developed for hard-to-treat forms of depression and post-traumatic stress disorder (PTSD), the latest step by the Trump administration toward...
Comments (0)